Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis

Summary

The primary purpose of this study is to identify an appropriate dose of study medication.

Timeline

Start

2012-06

Primary completion

2013-06

Completion

2015-06

Drugs

Indications